Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy - Trial NCT05430828
Access comprehensive clinical trial information for NCT05430828 through Pure Global AI's free database. This phase not specified trial is sponsored by Federico II University and is currently Completed. The study focuses on Hypercholesterolemia. Target enrollment is 798 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Federico II University
Timeline & Enrollment
N/A
Mar 07, 2020
Feb 01, 2022
Primary Outcome
Description of adherence of treatment with PCSK9 inhibitors in a real-life Italian population.,Description of persistence of treatment with PCSK9 inhibitors in a real-life Italian population.,Description of efficacy of treatment with PCSK9 inhibitors in a real-life Italian population.
Summary
Evaluation of adherence, persistence and efficacy of treatment with PCSK9 inhibitors in a
 real-life Italian population.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05430828
Non-Device Trial